Chickenpox in Poland in 2022.

Q3 Medicine
Przeglad epidemiologiczny Pub Date : 2024-12-10 Epub Date: 2024-11-12 DOI:10.32394/pe/195722
Jakub Maciej Zbrzeżniak, Iwona Paradowska-Stankiewicz
{"title":"Chickenpox in Poland in 2022.","authors":"Jakub Maciej Zbrzeżniak, Iwona Paradowska-Stankiewicz","doi":"10.32394/pe/195722","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chickenpox is an infectious disease caused by the Varicella-zoster virus, usually affecting children. It is characterized by a rash with rapid seeding of small red papules. The course of the disease is mild, but in people with weakened immunity it may be severe.</p><p><strong>Objective: </strong>The aim of the study was to assess the epidemiological situation of chickenpox in Poland in 2022 compared to the situation in previous years.</p><p><strong>Material and methods: </strong>Data from epidemiological surveillance, including mandatory reporting of cases by physicians, were used to assess the epidemiological situation of chickenpox in Poland.</p><p><strong>Results: </strong>In 2022, 171 708 cases of chickenpox were recorded, of which 87.5% were children under 9 years old. Hospitalization due to chickenpox was not one of the most common, the percentage of hospitalized cases oscillated between 0.12% and 1.24% depending on the voivodeship. Analyzing the incidence for the whole of Poland for the last 10 years, we see a drastic decrease from 470.6 in 2019 to 186.6 in 2020 and another decrease in 2021 to 151.1 per 100 000, to then return to an incidence of 453.9 in 2022.</p><p><strong>Conclusion: </strong>The incidence of chickenpox in 2022 returned to pre-pandemic levels, similar to those seen in 2016-2018. Despite preventive measures taken throughout the pandemic, significant incidence was observed, underlining the key role of vaccination in preventing this disease. The use of a quadrivalent vaccine against rubella, measles, mumps, and varicella could help reduce the costs associated with chickenpox, with a small increase in the costs of the vaccination program.</p>","PeriodicalId":20777,"journal":{"name":"Przeglad epidemiologiczny","volume":"78 3","pages":"351-358"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad epidemiologiczny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32394/pe/195722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chickenpox is an infectious disease caused by the Varicella-zoster virus, usually affecting children. It is characterized by a rash with rapid seeding of small red papules. The course of the disease is mild, but in people with weakened immunity it may be severe.

Objective: The aim of the study was to assess the epidemiological situation of chickenpox in Poland in 2022 compared to the situation in previous years.

Material and methods: Data from epidemiological surveillance, including mandatory reporting of cases by physicians, were used to assess the epidemiological situation of chickenpox in Poland.

Results: In 2022, 171 708 cases of chickenpox were recorded, of which 87.5% were children under 9 years old. Hospitalization due to chickenpox was not one of the most common, the percentage of hospitalized cases oscillated between 0.12% and 1.24% depending on the voivodeship. Analyzing the incidence for the whole of Poland for the last 10 years, we see a drastic decrease from 470.6 in 2019 to 186.6 in 2020 and another decrease in 2021 to 151.1 per 100 000, to then return to an incidence of 453.9 in 2022.

Conclusion: The incidence of chickenpox in 2022 returned to pre-pandemic levels, similar to those seen in 2016-2018. Despite preventive measures taken throughout the pandemic, significant incidence was observed, underlining the key role of vaccination in preventing this disease. The use of a quadrivalent vaccine against rubella, measles, mumps, and varicella could help reduce the costs associated with chickenpox, with a small increase in the costs of the vaccination program.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Przeglad epidemiologiczny
Przeglad epidemiologiczny Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
64
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信